...cardiovascular drugs ($17 billion), cholesterol-lowering drugs ($10 billion), hormones ($8 billion), central nervous system drugs ($7 billion), and gastrointestinal drugs ($6 billion)...
read more | digg story
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment